INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells

Abstract : Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G2-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response. Cancer Res; 72(8); 2006-16. ©2012 AACR.
Type de document :
Article dans une revue
Cancer Research, American Association for Cancer Research, 2012, 72, pp.2006-2016. 〈10.1158〉
Liste complète des métadonnées

https://hal-ens-lyon.archives-ouvertes.fr/ensl-00807724
Contributeur : Agnès Ganivet <>
Soumis le : jeudi 4 avril 2013 - 11:10:48
Dernière modification le : jeudi 8 février 2018 - 11:09:30

Identifiants

  • HAL Id : ensl-00807724, version 1
  • DOI : 10.1158

Collections

Citation

Christelle Morris-Desbois, Nozomi Tomimatsu, Derek J. Richard, David Cluet, Sandeep Burma, et al.. INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells. Cancer Research, American Association for Cancer Research, 2012, 72, pp.2006-2016. 〈10.1158〉. 〈ensl-00807724〉

Partager

Métriques

Consultations de la notice

89